Provention Bio Inc (PRVB)
8.00
-1.74 -17.82%
NASDAQ
Apr 9, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.85 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -98.58M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 507.00M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | 4.564 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -25.39M |
| Return on Equity | Upgrade |
View All PRVB News
News
-
WireHeadlineTime (ET)
-
MT Newswires04/09 16:26
-
MT Newswires04/09 15:54
-
MT Newswires04/09 13:53
-
MT Newswires04/09 12:46
-
SA Breaking News04/09 12:39
-
SA Breaking News04/09 12:16
-
MT Newswires04/09 12:14
-
MT Newswires04/09 11:41
-
SA Breaking News04/09 11:00
-
MT Newswires04/09 09:57
-
MT Newswires04/09 09:56
-
MT Newswires04/09 09:14
-
SA Breaking News04/09 09:11
-
MT Newswires04/09 09:04
-
MT Newswires04/09 08:45
-
SA Breaking News04/09 08:27
-
Yahoo04/09 07:39
-
Yahoo04/09 07:34
-
Yahoo04/09 06:30
-
MT Newswires04/08 17:47
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/07/2020 16:30 EDT | Earnings Calls | Q1 2020 Earnings Call |
| 05/07/2020 00:00 | Earnings Results | Q1 2020 Earnings Results |
| 07/15/2020 09:00 EDT | Agm | 2019 Annual General Meeting |
| 08/06/2020 00:00 | Earnings Results | Q2 2020 Earnings Results |
| 08/06/2020 08:00 EDT | Earnings Calls | Q2 2020 Earnings Call |
| 11/05/2020 00:00 | Earnings Results | Q3 2020 Earnings Results |
| 11/05/2020 08:00 EDT | Earnings Calls | Q3 2020 Earnings Call |
| 02/25/2021 00:00 | Earnings Results | Q4 2020 Earnings Results |
| 02/25/2021 08:00 EST | Earnings Calls | Q4 2020 Earnings Call |
| 05/07/2021 00:00 | Earnings Results | Q1 2021 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.proventionbio.com
- Investor Relations URL: N/A
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: May. 07, 2021
- Last Earnings Release: Feb. 25, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in sourcing, developing, and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease, including oncological, autoimmune, and inflammatory diseases. The company's product candidates include PRV-031, for the interception, delay, or prevention of type 1 diabetes; PRV-3279, for the potential treatment of systemic lupus erythematosus; and PRV-6527, PRV-300, and PRV-101.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 8.00 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRVB Tweets Stocktwits
Advertisement
